Reduced GST on cancer drugs : Step towards greater affordability, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

The government announcement of slashing GST on cancer drugs has been one of the long standing demands of the healthcare industry and is seen as a positive step for a segment which predominantly relies on imports but with more than 1.4 million cancer cases which are expected to grow further at a annual growth rate of 12.8 per cent quintessentially requires a robust ecosystem to fight the inflating load., The government announcement of slashing GST on cancer drugs has been one of the long standing demands of the healthcare industry and is seen as a positive step for a segment which predominantly relies on imports but with more than 1.4 million cancer cases which are expected to grow further at a annual growth rate of 12.8 per cent quintessentially requires a robust ecosystem to fight the inflating load., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *